The accuracy of magnetic resonance imaging in prostate cancer staging: a single-institution experience

Irish Journal of Medical Science

Volumn 184, Issue 2, 2015, Pages 313-317

  Oon, S F ^a   Power, S P ^a   Kelly, J S ^a   McDermott, V ^a   Ryan, P ^a   Ryan, P C ^a  

^a BON SECOURS HOSPITAL   (Ireland)

Author keywords

Imaging; Magnetic resonance imaging; Multiparametric; Prostate cancer; Staging

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

BLOOD; CANCER GRADING; CANCER STAGING; COMPARATIVE STUDY; HUMAN; MALE; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PREDICTIVE VALUE; PROSTATECTOMY; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDY; TUMOR INVASION;

HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES;

EID: 84897350887     PISSN: 00211265     EISSN: 18634362     Source Type: Journal    
DOI: 10.1007/s11845-014-1109-0     Document Type: Article

References (24)

1. Heidenreich A, Bellmunt J, Bolla M, Joniau S, Mason M, Matveev V, Mottet N, Schmid HP, van der Kwast T, Wiegel T, Zattoni F (2011) EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localised disease. Eur Urol 59(1):61–71. doi:10.1016/j.eururo.2010.10.039
2. Epstein JI, Pizov G, Walsh PC (1993) Correlation of pathologic findings with progression after radical retropubic prostatectomy. Cancer 71(11):3582–3593
3. Oon SF, Watson RW, O’Leary JJ, Fitzpatrick JM (2011) Epstein criteria for insignificant prostate cancer. BJU Int 108(4):518–525. doi:10.1111/j.1464-410X.2011.09979.x
4. Ward JF, Slezak JM, Blute ML, Bergstralh EJ, Zincke H (2005) Radical prostatectomy for clinically advanced (cT3) prostate cancer since the advent of prostate-specific antigen testing: 15-year outcome. BJU Int 95(6):751–756. doi:10.1111/j.1464-410X.2005.05394.x
5. Yossepowitch O, Eggener SE, Bianco FJ Jr, Carver BS, Serio A, Scardino PT, Eastham JA (2007) Radical prostatectomy for clinically localized, high risk prostate cancer: critical analysis of risk assessment methods. J Urol 178(2):493–499. doi:10.1016/j.juro.2007.03.105 (discussion 499)
6. Smith JA Jr, Scardino PT, Resnick MI, Hernandez AD, Rose SC, Egger MJ (1997) Transrectal ultrasound versus digital rectal examination for the staging of carcinoma of the prostate: results of a prospective, multi-institutional trial. J Urol 157(3):902–906
7. Fuchsjager M, Shukla-Dave A, Akin O, Barentsz J, Hricak H (2008) Prostate cancer imaging. Acta Radiol 49(1):107–120. doi:10.1080/02841850701545821
8. Heijmink SW, Futterer JJ, Hambrock T, Takahashi S, Scheenen TW, Huisman HJ, Hulsbergen-Van de Kaa CA, Knipscheer BC, Kiemeney LA, Witjes JA, Barentsz JO (2007) Prostate cancer: body-array versus endorectal coil MR imaging at 3 T—comparison of image quality, localization, and staging performance. Radiology 244(1):184–195. doi:10.1148/radiol.2441060425
9. Brajtbord JS, Lavery HJ, Nabizada-Pace F, Senaratne P, Samadi DB (2011) Endorectal magnetic resonance imaging has limited clinical ability to preoperatively predict pT3 prostate cancer. BJU Int 107(9):1419–1424. doi:10.1111/j.1464-410X.2010.09599.x
10. Duncan K WR (2010) How accurate is MRI staging of prostate cancer? http://www.rcr.ac.uk/audittemplate.aspx?PageID=1020&AuditTemplateID=169. Accessed 9 June 2013
11. Epstein JI, Carmichael MJ, Pizov G, Walsh PC (1993) Influence of capsular penetration on progression following radical prostatectomy: a study of 196 cases with long-term followup. J Urol 150(1):135–141
12. Panebianco V, Sciarra A, Marcantonio A, Forte V, Biondi T, Laghi A, Catalano C (2012) Conventional imaging and multiparametric magnetic resonance (MRI, MRS, DWI, MRP) in the diagnosis of prostate cancer. Q J Nucl Med Mol Imaging 56(4):331–342
13. da Silva RC, Sasse AD, Matheus WE, Ferreira U (2013) Magnetic resonance image in the diagnosis and evaluation of extra-prostatic extension and involvement of seminal vesicles of prostate cancer: a systematic review of literature and meta-analysis. Int Braz J Urol 39(2):155–166. doi:10.1590/S1677-5538.IBJU.2013.02.02
14. Beyersdorff D, Ludemann L, Dietz E, Galler D, Marchot P, Franiel T (2011) Dynamic contrast-enhanced MRI of the prostate: comparison of two different post-processing algorithms. RoFo: Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin 183(5):456–461. doi:10.1055/s-0029-1246051
15. Ikonen S, Karkkainen P, Kivisaari L, Salo JO, Taari K, Vehmas T, Tervahartiala P, Rannikko S (1998) Magnetic resonance imaging of clinically localized prostatic cancer. J Urol 159(3):915–919
16. Nakashima J, Tanimoto A, Imai Y, Mukai M, Horiguchi Y, Nakagawa K, Oya M, Ohigashi T, Marumo K, Murai M (2004) Endorectal MRI for prediction of tumor site, tumor size, and local extension of prostate cancer. Urology 64(1):101–105. doi:10.1016/j.urology.2004.02.036
17. Kim B, Breau RH, Papadatos D, Fergusson D, Doucette S, Cagiannos I, Morash C (2010) Diagnostic accuracy of surface coil magnetic resonance imaging at 1.5 T for local staging of elevated risk prostate cancer. Can Urol Assoc J 4(4):257–262
18. Yu KK, Hricak H, Alagappan R, Chernoff DM, Bacchetti P, Zaloudek CJ (1997) Detection of extracapsular extension of prostate carcinoma with endorectal and phased-array coil MR imaging: multivariate feature analysis. Radiology 202(3):697–702
19. Wang L, Hricak H, Kattan MW, Chen HN, Kuroiwa K, Eisenberg HF, Scardino PT (2007) Prediction of seminal vesicle invasion in prostate cancer: incremental value of adding endorectal MR imaging to the Kattan nomogram. Radiology 242(1):182–188. doi:10.1148/radiol.2421051254
20. Oon SF, Pennington SR, Fitzpatrick JM, Watson RW (2011) Biomarker research in prostate cancer—towards utility, not futility. Nature Rev Urol 8(3):131–138. doi:10.1038/nrurol.2011.11
21. Carver BS, Bianco FJ Jr, Scardino PT, Eastham JA (2006) Long-term outcome following radical prostatectomy in men with clinical stage T3 prostate cancer. J Urol 176(2):564–568. doi:10.1016/j.juro.2006.03.093
22. Joniau S, Tosco L, Briganti A, Vanden Broeck T, Gontero P, Karnes RJ, Spahn M, Van Poppel H (2013) Results of surgery for high-risk prostate cancer. Curr Opin Urol 23(4):342–348. doi:10.1097/MOU.0b013e3283620f60
23. Akakura K, Suzuki H, Ichikawa T, Fujimoto H, Maeda O, Usami M, Hirano D, Takimoto Y, Kamoto T, Ogawa O, Sumiyoshi Y, Shimazaki J, Kakizoe T (2006) A randomized trial comparing radical prostatectomy plus endocrine therapy versus external beam radiotherapy plus endocrine therapy for locally advanced prostate cancer: results at median follow-up of 102 months. Jpn J Clin Oncol 36(12):789–793. doi:10.1093/jjco/hyl115
24. Stephenson AJ, Bolla M, Briganti A, Cozzarini C, Moul JW, Roach M 3rd, van Poppel H, Zietman A (2012) Postoperative radiation therapy for pathologically advanced prostate cancer after radical prostatectomy. Eur Urol 61(3):443–451. doi:10.1016/j.eururo.2011.10.010